12 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 12 of 12 clinical reviews.
A clinician-reviewed guide to exercise prescription for adults with obesity (BMI ≥30), covering AHA, ACSM, and Endocrine Society recommendations with specific protocols, doses, and trial data.
Evidence-based guide to caregiver support, family-based interventions, and practical resources for managing obesity (BMI ≥30), including behavioral strategies, medication awareness, and clinical guidelines from ADA, AACE, and the Endocrine Society.
A step-by-step clinical algorithm for diagnosing obesity (BMI ≥30), staging severity, screening for comorbidities, and determining eligibility for FDA-approved pharmacotherapy or bariatric surgery, with society guideline citations and RCT data.
A guideline-backed monitoring schedule for adults with obesity (BMI ≥30), covering lab work, vitals, metabolic panels, and follow-up intervals during pharmacotherapy and lifestyle intervention.
A head-to-head comparison of major society guidelines for diagnosing and treating obesity (BMI ≥30), including pharmacotherapy thresholds, lifestyle targets, and surgery criteria from ADA, AACE, Endocrine Society, and USPSTF.
Complete clinical guide to nutrition, physical activity, and behavioral protocols for obesity (BMI ≥30), including ADA, AACE, and Endocrine Society guidelines, RCT evidence, and FDA-approved pharmacotherapy thresholds.
A clinical review of the most promising obesity trials, next-generation GLP-1 receptor agonists, combination therapies, and gene-based approaches reshaping how we treat BMI ≥30.
Obesity and mental health disorders share biological, psychological, and pharmacological pathways. Learn how depression, anxiety, binge eating, and weight-related stigma interact with BMI ≥30, and what evidence-based treatments address both.
A clinician-reviewed guide to the most common obesity comorbidities, including type 2 diabetes, cardiovascular disease, MASLD, OSA, and osteoarthritis, with prevalence data and guideline-based screening recommendations.
How genetics and family history influence obesity risk, BMI heritability, known gene variants like MC4R and FTO, and what this means for GLP-1 and other treatments.
Step-by-step obesity treatment algorithm organized by line of therapy, from lifestyle intervention through pharmacotherapy and metabolic surgery, based on ADA, AACE, and Endocrine Society guidelines.
How obesity management differs for older adults, adolescents, pregnant patients, and those with CKD, diabetes, or psychiatric conditions. Guideline-backed strategies with trial data.